MD SB942

Repeals the requirement that local correctional facilities make available at least one formulation of each FDA-approved opioid agonist, partial agonist, and long-acting antagonist for treating opioid use disorders

Requires the Secretary of Health to provide annual grants to each county equal to their costs for implementing medication-assisted treatment programs in local correctional facilities, funded through the Opioid Restitution Fund and state budget appropriations

Mandates counties submit annual reports by October 1 to the Office of Overdose Response detailing treatment days per incarcerated individual, itemized costs, and other required information, with a 20% grant reduction penalty for each 30 days reports are late

Expands authorized uses of the Opioid Restitution Fund to include grants to counties for medication-assisted treatment program implementation in correctional facilities

Takes effect October 1, 2025